Skip to main content

Table 2 Cost-effectiveness of an intervention based on baseline ventilator-associated pneumonia rate and its relative risk reduction

From: Number needed to treat and cost-effectiveness in the prevention of ventilator-associated pneumonia

 

Relative risk reduction

 

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

Baseline VAP rate

          

1%

£5

£10

£15

£20

£25

£30

£35

£40

£45

£50

2%

£10

£20

£30

£40

£50

£60

£70

£80

£90

£100

4%

£20

£40

£60

£80

£100

£120

£140

£160

£180

£200

6%

£30

£60

£90

£120

£150

£180

£210

£240

£270

£300

8%

£40

£80

£120

£160

£200

£240

£280

£320

£360

£400

10%

£50

£100

£150

£200

£250

£300

£350

£400

£450

£500

15%

£75

£150

£225

£300

£375

£450

£525

£600

£675

£750

20%

£100

£200

£300

£400

£500

£600

£700

£800

£900

£1,000

  1. Values (£) refer to the average additional expense that can be spent for an intervention, per 10 days of mechanical ventilation, for it to be cost-neutral assuming a VAP cost of £10,000. VAP, ventilator-associated pneumonia.